Alterações

*''Synthetic phosphoethanolamine a precursor of membrane phospholipids reduce tumor growth in mice bearing melanoma B16-F10 and in vitro induce apoptosis and arrest in G2/M phase'' <ref>[https://pubmed.ncbi.nlm.nih.gov/22902646 Synthetic phosphoethanolamine a precursor of membrane phospholipids reduce tumor growth in mice bearing melanoma B16-F10 and in vitro induce apoptosis and arrest in G2/M phase]</ref>;

*''Anticancer effects of synthetic phosphoethanolamine on Ehrlich ascites tumor: an experimental study'' <ref>[https://pubmed.ncbi.nlm.nih.gov/22213293 Anticancer effects of synthetic phosphoethanolamine on Ehrlich ascites tumor: an experimental study]</ref>;

*''Synthetic phosphoethanolamine has in vitro and in vivo anti-leukemia effects <ref>[https://www.nature.com/articles/bjc2013510 Synthetic phosphoethanolamine has in vitro and in vivo anti-leukemia effects]</ref>;

*''Synthetic phosphoethanolamine induces cell cycle arrest and apoptosis in human breast cancer MCF-7 cells through the mitochondrial pathway'' <ref>[https://pubmed.ncbi.nlm.nih.gov/23773853 Synthetic phosphoethanolamine induces cell cycle arrest and apoptosis in human breast cancer MCF-7 cells through the mitochondrial pathway]</ref>;

*''Anti-angiogenic and anti-metastatic activity of synthetic phosphoethanolamine'' <ref>[https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0057937 Anti-angiogenic and anti-metastatic activity of synthetic phosphoethanolamine]</ref>;